As the field of allergy and immunology changes, there has been an explosion of new insights into the pathophysiology of many of the diseases allergists treat. Furthermore, these insights are being translated into novel therapeutic options that promise tremendous benefit to patients for whom there were few options in the recent past. Given the rapidly growing knowledge base, many clinicians have difficulty keeping up with the latest developments, particularly in disease states that are less commonly encountered.

During the Allergy Partners 2020 Summer Series we reviewed advances in a number of disease states, including Atopic Dermatitis, Hereditary angioedema, Humoral Immune Deficiency, and Alpha-1 Antitrypsin deficiency as well as advances in food allergy and the changing landscape of consumer driven healthcare.

This series is free and open to all allergist/immunologists and their clinic staffs.